cyanotic congenital heart disease have elevated systemic levels of VEGF [20] . We hypothesized that one or both of these angiogenic factors, VEGF and HGF, was related to the abnormal angiogenesis demonstrated by children with cyanotic congenital heart disease. In this study we evaluated plasma levels of VEGF and HGF in patients with cyanotic heart disease and compared them with the plasma levels in healthy subjects to determine whether these angiogenic factors were elevated in the presence of cyanosis. 
MATERIALS AND METHODS

DISCUSSION
Patients with cyanotic congenital heart disease often develop aortopulmonary collateral arteries [16] [17] [18] [19] . It seems that the development of these aortopulmonary collateral vessels is associated with the severity of the cyanosis. These aortopulmonary collateral vessels may be the major cause of remaining left to light shunts and place a hemodynamic burden on the systemic ventricle in patients having Fontan procedure [19] . Therefore, these vessels are usually closed by transcatheter coil occlusion before or after the operation [17] . The mechanism of development of aortopulmonary collateral vessels is not clear. We hypothesized that persistent systemic hypoxia may induce angiogenesis in patients with cyanotic congenital heart disease, and, as a result, these aortopulmonary collateral arteries may develop.
In this study, we evaluated the plasma concentrations of VEGF and HGF in patients with cyanotic congenital heart disease and healthy control subjects to determine whether the presence of cyanosis influenced these angiogenic factors.
In our study, the plasma concentration of VEGF in normal infants was clearly elevated in the neonatal period, gradually decreasing to the normal range within a few months after birth. Ariadne and colleagues reported that the plasma level of VEGF rose significantly in early neonatal life compared with the levels in umbilical cord blood [21] . Increase of VEGF in the early neonatal period may reflect the physiological development of vessels in the neonatal period [22] . Otherwise, it may reflect transient hypoxia at delivery or sudden hemodynamic changes soon after birth, such as the increase of pulmonary blood flow, etc [13, 14, 23] . In this study, we demonstrated that elevated plasma concentrations of VEGF in the early neonatal period rapidly decreased to the adult range within a few months after birth. This change may be caused by the stabilization of hemodynamics or by the end of advanced VEGF expression in the neonatal period. However, plasma HGF did not show such age dependency. In our study, VEGF levels in the cyanotic group were significantly higher than that in the acyanotic control group over 3 months after birth. Plasma concentrations of VEGF may be elevated regardless of the presence of cyanosis in the neonatal period, and immediately decrease to the adult range in the normal acyanotic group. Elevated VEGF levels in the neonatal period in patients with cyanosis may be maintained beyond 3 months. Hypoxia could be considered a strong stimulus for angiogenesis, and leads to an increase of angiogenic factors under hypoxic conditions in the experimental model [15, 24] . Recent reports demonstrated that increased serum VEGF levels in athletes who were trained in high altitude conditions [12] . The role of VEGF as an angiogenic stimulator is well established, and therefore VEGF is a candidate for mediating the abnormal proliferation of blood vessels (i.e. aortopulmonary collateral arteries) in patients with hypoxic conditions.
However, HGF levels did not differ between cyanotic and acyanotic groups, and also did not show any correlation with oxygen saturation. These results suggested that VEGF and HGF were probably induced by different mechanisms.
If VEGF expressions are linked with abnormal collateral formations in patients with cyanotic heart disease, gene therapy using VEGF inhibitors would be possible in the future.
Several limitations were present in this study. The sample sites, either the peripheral vein or the inferior vena cava, were not fixed in either the cyanotic or control group. However, no significant differ-ences between VEGF levels of the peripheral vein and the IVC were found in our study. Another limitation in this study was 
